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ABSTRACT
Central venous catheters (CVCs) are inserted in order to administer fluids and
medications. A peripherally inserted central catheter (PICC) is a type of CVC. While beneficial,
central line associated bloodstream infection (CLABSI) is a risk for patients having a CVC
inserted. Antiseptics are used for skin preparation when inserting a central line to prevent
infection and during maintenance of the central line. Currently, the Center for Disease Control
recommends the use of chlorhexidine for central venous catheter insertion in patients two months
of age or older. Studies have found reduced CLABSI rates with the use of chlorhexidine for
CVC insertion and maintenance in neonates. Research has also found chlorhexidine to have a
more substantial and longer lasting effect than povidone- iodine as an antiseptic. However,
studies have also noted concerns related to skin irritation and burns in low weight neonates with
the use of chlorhexidine. Additional research is needed to determine the efficacy of
chlorhexidine in preventing CLABSI infections in the neonatal population.
This study compared the CLABSI rate in a Northwest Arkansas neonatal intensive care
unit (NICU) with the use of povidone-iodine versus chlorhexidine as the antiseptic for PICC line
maintenance. The study examined all neonates in the NICU who had a PICC line. The data was
analyzed using a descriptive statistics examining CLABSI with the use of povidone-iodine
versus chlorhexidine as the antiseptic. One CLABSI occurred during the povidone-iodine
protocol. No infection occurred during the chlorhexidine protocol. Because of the small infection
rate during the timeframe of this study, it was concluded that both antiseptics were effective at
preventing CLABSI in neonates with PICCs. This study was limited in scope and timeframe
therefore more extensive research could be conducted to further examine if the new
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chlorhexidine protocol is more effective at preventing CLABSI in the neonatal population with
PICCs.

Is chlorhexidine an effective antiseptic to prevent CLABSI for PICC line maintenance in
the neonatal population?
INTRODUCTION
Central venous catheters (CVCs) are inserted when necessary to administer medications
and intravenous fluid. The insertion of a CVC while beneficial, places the patient at risk of
complications of a central line associated bloodstream infection (CLABSI) (Curry, Honneycutt,
Goins, & Gilliam, 2009). According to the National Healthcare Safety Network, CLABSI occurs
at a rate of 3.1-6.4 per 1,000 CVC days in the neonatal intensive care unit (NICU) (Edwards, et
al, 2007).
Antiseptics are used for skin preparation prior to CVC insertion and during maintenance
to reduce the incidence of infection. Povidone-iodine is currently used for CVC skin preparation
in neonatal patients. However, CLABSIs are still a major concern in the NICU. Chlorhexidine is
a topical antiseptic solution that has clinically been shown to be a safe and effective antiseptic in
adults and children for hand washing and preoperative skin preparation (Milstone, Passaretti &
Peri, 2008). Currently, the CDC recommends the use of 0.5% chlorhexidine gluconate with
alcohol for skin preparation before CVC and peripheral arterial catheter insertion and during
dressing changes in adults and children older than two months of age. The Center for Disease
Control (CDC) makes no recommendation for the use of chlorhexidine in infants under two
months old (CDC, 2011). The efficacy of chlorhexidine in the reduction of CLABSIs in the
neonatal population is in need of further research.
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Although the CDC has not approved chlorhexidine for use in children less than 2 months
of age, a national survey found that 61% of US NICUs are using chlorhexidine for CVC line
insertion and maintenance. Fifty one percent of these NICUs restrict the use of chlorhexidine by
birth weight, gestational age, or chronological age. Forty two percent restricted chlorhexidine use
by gestational age of 28 weeks or less, 40% restricted by birth weight, 1000g or less, and 26%
restricted by chronological age, of less than two weeks. The other 49% used chlorhexidine
without restriction (Tamma, Aucott & Milstone, 2010).
Chlorhexidine has been shown to be an effective antiseptic in low birth weight infants.
One time skin cleansing with 0.25% chlorhexidine reduced colonization by 62% compared to no
cleansing (Sankar et al., 2009).
Research compared the efficacy of povidone-iodine and chlorhexidine. A study
comparing the effectiveness of chlorhexidine to povidone iodine and sodium hypochlorite found
all antiseptics were comparable for short procedures but found chlorhexidine to be the only
antiseptic with a substantive effect, indicating that the antiseptic is effective against the
introduction of new organisms over time. Chlorhexidine is recommended for longer procedures
such as indwelling catheter insertion and surgery (Macias et al., 2013). However, in a pilot trial
conducted in 2009 comparing the use of povidone-iodine (10%) to chlorhexidine gluconate (2%)
for the insertion of CVC in neonates seven days of age or older and weighing over 1500 g, no
statistically significant difference in infection rates between the two antiseptics was found
(Garland et al., 2009). A study published in 2001 found the use of chlorhexidine-impregnated
dressing and 70% alcohol scrub to be as effective as 10% povidone iodine in preventing CRBSI
(catheter related bloodstream infection) and BSI (bloodstream infection) in neonates (Garland et
al., 2001).
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Chlorhexidine is not currently recommended for use in neonates less than 2 months of
age due to concerns related to skin integrity. A study in a NICU found severe contact dermatitis
in very low birth weight infants with the use of chlorhexidine gluconate impregnated patches.
The trial continued excluding infants less than 800g or less than 7 days old and found only three
reactions of the remaining 75 participants (Garland, Alex, Mueller & Cisler-Kahill, 1996).
Garland and coworker’s study (2001) found contact dermatitis only in neonates under 1000g
with use of Chlorhexidine impregnated dressings. A more recent study comparing provodineIodine to chlorhexidine gluconate did not find any contact dermatitis with the use of
chlorhexidine gluconate in neonates over 1500g. The study did result in a case of contact
dermatitis with the use of povidone iodine (Garland et al., 2009). One time skin cleansing with
0.25% chlorhexidine did not cause adverse skin effect or induce hypothermia in neonates 10012000g (Sankar et al., 2009). In a national survey of NICUs, 17 of the participating NICUs
reported burns from using chlorhexidine in which 13 of the cases were in neonates less than
1500g (Tamma, Aucott & Milstone, 2010).
Another concern related to the use of chlorhexidine in neonates is absorption of the
antiseptic into the bloodstream. A study comparing provodine-iodine to chlorhexidine gluconate
found that chlorhexidine gluconate was absorbed into the bloodstream of the neonates. However,
no significant side effects were reported in the trial (Garland et al., 2009).
Studies have found implementation of central line bundles in the NICU, including the use
of chlorhexidine as an antiseptic; have shown a statistically significant decrease in the number of
CLABSI infections (Schulman et al., 2011; Miller et al., 2011). Bundles are evidence-based
practices implemented as a group, at the same time, in a clinical setting (Butler-O’Hara,
D’Angio, Hoey & Stevens, 2012). These bundles provide protocol for central line insertion and
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site maintenance. A New York statewide implementation of a bundle including chlorhexidine
resulted in a 67% CLABSI rate decrease statewide (Schulman et al., 2011). Another study
implemented the use of chlorhexidine in all CVC catheter types in the NICU, which resulted in a
decrease in CLABSI infection rates among all catheter types and birth weight neonates (Sannoh,
Clones, Munoz, Montecalvo & Parvez, 2010).
A study completed by Arkansas Children’s hospital examined the impact of the
implementation of a CVC site bundle consisting of best practice measures to reduce CLABSI.
The bundle included the use of chlorhexidine and alcohol as a skin antiseptic, and a
chlorhexidine impregnated patch around the catheter insertion site. This study included infants
greater than 2000g or who were greater than two weeks old. A substantial reduction in infection
rates from 4.9 infections per 1000 catheter days in 2005 to 2.1 infections per 1000 catheter days
in 2007 occurred despite an overall 40% increase in total line days (Curry, Honeycutt, Goins, &
Gillam, 2009). A similar three year study of 29 pediatric intensive care units (PICUs)
demonstrated a 56% decrease in the rate of CLABSI infections after bundle implementation
(Miller et al., 2011).
Further research is needed to determine the efficacy of chlorhexidine as an antiseptic in
neonates. Although concerns exist related to skin integrity, more recent studies have not resulted
in skin integrity issues. Bloodstream absorption of chlorhexidine is also a concern, but negative
side effects related to absorption have not been documented. Chlorhexidine has been shown to be
an effective antiseptic in both adults and children and implementation of bundles including the
use of chlorhexidine in the NICU have been successful in the reduction of CLABSIs.
AIMS
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The aim of this study will be to compare CLABSI rates in a Northwest Arkansas NICU
with use of povidone-iodine as an antiseptic to the rates of CLABSI following implementation of
a standard protocol using chlorhexidine for PICC line site maintenance.
Variables. The independent variables are the antiseptics used to maintain PICC lines,
povidone and chlorhexidine, and the dependent variable is the CLABSI rate.
METHODS
Design. A quasi-experimental study design using a pre- post design with two comparison
treatments was used in this study. This study used a retrospective chart review to evaluate the
variables.
Purposive sampling was used in this study. The sample included neonates receiving a
PICC line placement during the determined study period. The first group in the study consisted
of neonates admitted to the NICU between August-November 2012 who had a PICC line
inserted for greater than 24 hours and received the povidone-iodine protocol. The second group
consisted of neonates admitted to the NICU between August-November 2013 who had a PICC
line inserted for greater than 24 hours who received the chlorhexidine protocol.
Procedure. Prior to data collection, approval was obtained from the University of
Arkansas Institutional Review Board (IRB) and the Quality Improvement Department of study
hospital. Data was then collected from comparable time periods before the new protocol was
implemented and after implementation. Retroactive chart audits of all infants meeting the study
criteria were reviewed for CLABSI. Additional data including gestational age, birth weight, age
at time of PICC insertion, weight at time of PICC insertion, age at time of PICC removal, weight
at time of PICC removal, and length of time PICC was in use was collected. All data was deidentified.

IS CHLORHEXIDINE AN EFFECTIVE ANTISEPTIC TO PREVENT CLABSI?

8

RESULTS
Table 1
PICC inserted in the NICU during the 2012 Povidone-Iodine Protocol
Patient
Number
1
2
3
4
5
6
7

Gestational
Age
28 4/7
weeks
27 weeks
34 1/7
weeks
32 weeks
34 1/7
weeks
35 6/7
weeks
32 6/7

Birth
weight

Age at
PICC
insertion

Weight
at PICC
insertion

Age at
PICC
removal

Weight
at PICC
removal

Duration
of PICC

CLABSI

1090g

9 days

1220g

30 days

1800g

21 days

Positive

1080g

7 days

950g

31 days

1481g

24 days

Negative

2195g

2 days

2105g

8 days

2085g

6 days

Negative

1210g

8 days

1197g

22 days

1610g

14 days

Negative

2204g

1 day

2215g

8 days

2080g

7 days

Negative

3090g

5 days

2900g

9 days

3150g

4 days

Negative

2226g

2 days

2063g

25 days

2788g

23 days

Negative

Table 2
PICC inserted in the NICU during the 2013 Chlorhexidine Protocol
Patient
Number
1
2
3
4
5
6
7
8
9
10
11

Gestational
Age
35 1/7
weeks
33 weeks
33 weeks
37 4/7
weeks
31 5/7
weeks
31 5/7
weeks
32 1/7
weeks
29 weeks
33 weeks
34 1/7
weeks
38 weeks

Birth
weight

Age at
PICC
insertion

Weight
at PICC
insertion

Age at
PICC
removal

Weight
at PICC
removal

Duration
of PICC

CLABSI

2537g

2 days

2565

7 days

2548 g

5 days

Negative

1840g
2015g

2 days
10 days

1690g
2000g

9 days
24 days

1810g
2561g

7 days
14 days

Negative
Negative

2460g

6 days

2490g

N/A

N/A

N/A

N/A

1735g

4 days

1648g

12 days

2079g

8 days

Negative

1570g

2 days

1518g

18 days

1739g

16 days

Negative

1625g

0 days

1625g

8 days

1613g

8 days

Negative

1245g
2010g

7 days
1 day

1170g
1940g

14 days
7 days

2178g
2045g

7 days
6 days

Negative
Negative

1510g

4 days

1438g

14 days

1668g

10 days

Negative

2983g

3 days

2880g

7 days

2835g

4 days

Negative
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Data was analyzed using descriptive analysis. The data from the povidone-iodine
protocol was compared to that under the chlorhexidine protocol regarding CLABSI rates,
gestational age, birth weight, age at time of PICC insertion, weight at time of PICC insertion, age
at time of PICC removal, weight at time of PICC removal, and length of time PICC was in use.
Under the povidone-iodine protocol between August and October 2012 seven PICC lines
were inserted (Table 1). The gestational ages of the infants with PICC lines ranged from 27 to 35
6/7 weeks with an average gestational age of 32.07 weeks (Table 1). The birth weight of the
infants ranged from 1080g to 3090g with an average of 1870g (Table 1). The age at time of
insertion of the PICC line ranged from 1 to 9 days with an average of 4.85 days (Table 1). The
infant weight at time of insertion of the PICC ranged from 950g to 2900g with an average of
1807.1g (Table 1). The age ranges on removal of the PICC was 8 to 31 days with an average
time of 19 days (Table 1). The weight at time of PICC removal ranged from 1481g to 3150g with
an average of 2142g (Table 1). The range PICC line duration was 4 to 24 days with an average of
14.1 days (Table 1). Under the chlorhexidine protocol between August and October 2013
eleven PICC lines were inserted (Table 2). The gestational ages of the infants with PICC lines
ranged from 31 5/7 to 38 weeks with an average gestational age of 33.5 weeks (Table 2). The
birth weight of the infants ranged from 1510g to 2983g with an average of 1957.3g (Table 2).
The age at time of insertion of the PICC line ranged from 0 to 10 with an average of 3.7 days
(Table 2). The infant weight at time of insertion of the PICC ranged from 1170g to 2880g with
an average of 1905.8g (Table 2). The age ranges on removal of the PICC was 7 to 24 days with
an average of 12 days (Table 2). The weight at time of PICC removal ranged from 1613g to
2835g with an average of 2107.6g (Table 2). The range PICC line duration was 4 to 16 days with
an average time of 8.5 days (Table 2).
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Of the data collected one CLABSI infection occurred. This infection occurred under the
previous povidone-iodine protocol in October 2012. The infection occurred in an infant born in
October 2012 who was 28 weeks gestation with a birth weight of 1090 grams. The infant was 9
days old upon insertion of the PICC line and weighed 1220g. The line blood cultures tested
positive for staphylococcus epidermis 19 and 21 days later. The PICC line was removed on day
21 when the infant was 30 days old and weighed 1800g.
DISCUSSION
In comparing the CLABSI rate under the previous Povidone-Iodine protocol and the new
chlorhexidine protocol minimal infection occurred. Only one CLABSI occurred under the
Povidone-Iodine protocol. While the infection rate was not significant at this facility, any
infection should be treated as a critical incident. That being said from the data collected, a
definite conclusion cannot be drawn as to if chlorhexidine is a more effective antiseptic than
povidone-iodine, however the data shows both antiseptics to be effective at preventing CLABSI
based on the low infection rates under both protocols.
The study was limited because the new chlorhexidine protocol was not fully implemented
to include chlorhexidine use on the skin during PICC line insertion. This study was also limited
in the scope and timeframe of data that could be included in the study. For neonate 4 under the
chlorhexidine protocol only part of the information could be obtained because the neonate was
transferred to a different hospital for care.
CONCLUSION
Based on the data collected this facility’s former and current protocols were both
effective at preventing CLABSI in neonates with PICCs. This study was limited in its scope of
data and timeframe that could be included. A larger more extensive study could be conducted to
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determine if both antiseptics prove to be equally effective at preventing CLABSI in neonates
with PICCs.
Research could also be conducted at this facility to determine employee compliance with
the new protocol to define what factors were most effective at preventing infection. Employee
compliance with documentation of PICC insertion, maintenance, and removal could also be
examined for improved standardization of documentation.
Further research should also be done at this facility after the new chlorhexidine protocol
is expanded to include skin contact with Chlorhexidine. During this study chlorhexidine use on
the skin was not implemented as part of the protocol. Research including the use of
chlorhexidine on the skin is needed to examine concerns related to the use of chlorhexidine in
neonates and skin integrity. Additional and more extensive research studies are needed to
develop standard restrictions based on age and weight for chlorhexidine skin contact with
neonates due to previous research conveying concerns related to skin integrity.
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